billy’s daily mental health startup news - 9/5/25

⚖️ FTC to investigate AI chatbots’ impact on children (Economic Times) – 9/3/25
Why it’s interesting: Regulators seeking internal documents on child safety from major AI firms

💊 Sensorium Therapeutics raises $25M for anxiety drug development (Ryan Cross, Endpoints News) – 8/19/25
Why it’s interesting: FDA cleared first-in-human trial for new anxiety treatment

🌐 Mamaya Health secures $2.5M for digital-first mental health care (Chris Larson, Behavioral Health Business) – 9/2/25
Why it’s interesting: Partnerships expand reach of women’s mental health platform

🧠 NewDays raises $7M seed to expand dementia care (Marissa Plescia, MedCity News) – 9/3/25
Why it’s interesting: AI-assisted cognitive therapy expanding access across more states

🧬 Polaris Genomics raises $250K debt for PTSD biomarker work (citybiz) – 9/3/25
Why it’s interesting: Company developing blood-based genomic test for PTSD diagnosis

📱 App OTX-202 cuts post-discharge suicide attempts by 58% (Jessica Walters, Psychiatric Times) – 8/29/25
Why it’s interesting: Shows digital CBT app reduces suicide risk after hospitalization

🏥 Baylor Scott & White forms behavioral health JV with Geode (Blake Madden, Hospitalogy) – 9/2/25
Why it’s interesting: First major health system joint venture for hybrid behavioral health care in Texas

🧠 Tolion to launch beta of AI brain health app (Business Wire) – 9/3/25
Why it’s interesting: App targets modifiable risk factors for Alzheimer’s and dementia prevention

Subscribe to news and reports about mental health startups & mental health investors at gimbhi.substack.com